ClinicalTrials.gov
5d ago· 1 min readNews
Source
bskyClinicalTrials.govclinicaltrials.govLilly posted its program for retatrutide in early June, but unlike postings for other drugs, it contains no information about the disease conditions or which patients might qualify. "Only people in the know would be able to find this," an expert said. clinicaltrials.gov/study/NCT076...
You might also wanna read
Unapproved weight-loss drug retatrutide widely available online, creating challenges for clinicians
Retatrutide, an investigational triple hormone receptor agonist not yet approved by the FDA for any indication, is being widely sold online
mdsc.pe·1d ago
Clinical Trials Exclude High-Risk Patients, Underestimating Drug Harms
This research paper examines how clinical trials systematically exclude high-risk patients, leading to underestimation of drug harms and sid
nber.org·6mo ago10 out of 12 people cured in Type 1 Diabetes Study
nejm.org·1y ago
Threat in Your Medicine Cabinet: The FDA's Gamble on America's Drugs
propublica.org·1y ago
Ask HN: What is the latest on treatment of Metastatic Breast Cancer?
news.ycombinator.com·1y ago
Redirecting
doi.org·9d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.